A phase 1 study of a personalized cancer vaccine demonstrated antitumor immunity in all treated patients with resected renal ...

The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...

A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

A Greeley clinic hopes to provide a less costly alternative for patients in need of infusions or injections of medications.

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...